Medscape

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women. […]

Individuals with type 2 diabetes and painful symptomatic knee osteoarthritis are less likely to achieve target glycemic control. Medscape Medical

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and quality of life

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious

COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID

Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate alone, in a trial of

A UK-led systematic review reports high rates of sexual dysfunction in individuals with axial spondyloarthritis, highlighting gaps in routine assessment

Bemotrizinol’s manufacturer said that it expects this ingredient to be available for use in sunscreens in the summer of 2026.

Adding romosozumab to ongoing denosumab treatment shows increased lumbar spine bone mineral density with preserved anabolic effect in postmenopausal women

In children born to mothers with chronic inflammatory diseases, the use of TNF inhibitors during pregnancy is not tied to

Better outcomes may come from new drugs, strategies to rev up the immune system and learning to identify the disease

At a roundtable discussion, speakers aired grievances about what they said was the lack of interest in the condition and

New evidence suggests that the risk for fracture increases within months of low-dose prednisone, challenging the idea of a safe

Transcutaneous auricular vagus nerve stimulation demonstrates safety and potential benefits in patients with erosive hand osteoarthritis but does not reduce

The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies.

Jonathan A. Bernstein, MD, discusses the latest advances in diagnosis and treatment of hereditary angioedema, including new therapies, clinical challenges,

The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, efficacy, and cost-effectiveness compared

The majority of knees without radiographic osteoarthritis experience an increase in structural damage over time, with the most frequent changes

Both partial and total knee replacement for medial compartment knee osteoarthritis show comparable effectiveness over the long term, with partial

A self-referral tool for patients with chronic back pain may be a feasible solution for identifying axial spondyloarthritis, enabling earlier

A retrospective study of all applicants for US rheumatology training from 2009 to 2024 found a persistent surplus of applicants

Patients with gout who receive 5 years of treat-to-target urate-lowering therapy achieve reductions in serum urate levels, ultrasound-detected crystal deposits,

Chronic chikungunya arthritis often mimics rheumatoid arthritis, complicating diagnosis and therapy, and necessitating careful immunosuppression decisions. Medscape News Europe

Having a history of thrombosis or hematologic disease was associated with an approximately twofold increased risk for incident thrombosis in

The most common symptoms are back pain, joint pain, and insomnia. Medscape Medical News

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of

An electronic consultation program, in which primary care providers seek input from specialists, enhances rheumatology care access and delivery in